CNTY-101 / Century Therap  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
CNTY-101 / Century Therap
CALiPSO-1, NCT06255028: A Study of CNTY-101 in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE)

Not yet recruiting
1
26
US
CNTY-101, IL-2, Lymphodepleting Chemotherapy
Century Therapeutics, Inc.
Systemic Lupus Erythematosus
08/28
08/28
ELiPSE-1, NCT05336409: A Study of CNTY-101 in Participants With CD19-Positive B-Cell Malignancies

Recruiting
1
75
US
CNTY-101, IL-2, Lymphodepleting Chemotherapy
Century Therapeutics, Inc.
R/R CD19-Positive B-Cell Malignancies, Indolent Non-Hodgkin Lymphoma, Aggressive Non-Hodgkin Lymphoma
08/25
08/27

Download Options